Cyclophosphamide for Injection, 1 gram/vial recall — Sunny Pharmtech Inc. (Class I)

Sunny Pharmtech Inc. is recorded by the U.S. Food and Drug Administration (FDA) as recalling Cyclophosphamide for Injection, 1 gram/vial — a Class I recall, initiated 2026-07-17 and posted to the FDA enforcement report on 2026-08-12, under recall number D-0743-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Presence of Particulate Matter; identified as stainless steel”. From the product description, the form is for injection, the strength given is 1 gram/vial, the package is described as One Single-Dose Vial and it is marked Rx only. 1 National Drug Code number is printed in the record: 81298-8112-1. Distribution is recorded as “USA Nationwide” — Nationwide (US), with the recalling firm on record in Taiwan. The FDA files it under event ID 99437 together with 1 other recall number, all listed and linked below. Within that event this is the strength 1 gram/vial and ndc 81298-8112-1 configuration; the sibling records differ on strength and ndc and match on everything else the source states. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0743-2026
FDA event ID 99437 (2 recall numbers)
Classification Class I (most serious regulatory tier)
Status Ongoing
Recalling firm Sunny Pharmtech Inc.
Recall initiated 2026-07-17
Reported by FDA 2026-08-12
Report lag 26 days from initiation to report
Distribution USA Nationwide — Nationwide (US)
Firm location on record Taiwan
Product description (source) Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1

Reason reported by FDA

Presence of Particulate Matter; identified as stainless steel

8 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

7 identifying values matched by exact pattern in the 25-word product description above; each is a literal substring of it.

Product named Cyclophosphamide for Injection
Form for Injection
Strength 1 gram/vial
Package One Single-Dose Vial
NDC 81298-8112-1
Marketing category Rx only
Stated origin Taiwan
Manufactured for Long Grove Pharmaceuticals, LLC

Which configuration this record is

2 recall numbers share event 99437. They differ on strength and ndc and agree on everything else the source states, so those are the values to check a package against.

Attribute This record (D-0743-2026) D-0744-2026
Strength 1 gram/vial 2 gram/vial
NDC 81298-8112-1 81298-8114-1

Shared across all 2 records under this event: package One Single-Dose Vial; form for Injection; product named Cyclophosphamide for Injection; fda tier Class I; recalling firm Sunny Pharmtech Inc.; the same reason text; initiated 2026-07-17; reported 2026-08-12.

Event context: 2 recall numbers under event 99437

One enforcement action, 2 recall numbers: the FDA filed 1 further configuration of this action under event 99437. Each keeps its own recall number and dates.

Recall recordRecall numberFDA tierStrength / formNDCReported
Cyclophosphamide for Injection, 2 gram/vialD-0744-2026Class I2 gram/vial · for Injection81298-8114-12026-08-12

Nearest Class I recalls by date

11 of 250 indexed records share the Class I tier; the 9 nearest to 2026-08-12 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
Cetirizine Hydrochloride Tablets USP 5 mgD-0732-2026JB Chemicals And Pharmaceuticals Ltd5 mg · Tablets2026-07-29
Revitaderm Wound Care Gel, 0.1%D-0692-2026Blaine Labs Inc0.1% · Gel2026-07-08
BD ChloraPrep Clear, 2%D-0624-2026Carefusion 213, LLC2% · Solution2026-07-01
BD ChloraPrep FREPP Clear, 2%D-0625-2026Carefusion 213, LLC2% · Solution2026-07-01
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mLD-0580-2026Sun Pharmaceutical Industries Inc50 mg/25 mL · Injection2026-06-17
Gas-X Extra Strength, 125 mgD-0595-2026Haleon US Holdings LLC125 mg · Softgels2026-06-17
BEEKEEPER'S NATURALS Saline Nasal Spray, 30 mLD-0620-2026Beekeeper's Naturals Usa Inc.30 mL · Nasal Spray2026-06-17
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%)D-0553-2026Wisconsin Pharmacal Company2% · Cream2026-05-27
Lactated Ringer's Injection USP, 1000 mLD-0540-2026B Braun Medical Inc1000 mL · Injection2026-05-13

Reading this record

Class I is the FDA's own severity tier for the recall action — 11 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. A search on event 99437 returns all 2 of these recall numbers; a search on D-0743-2026 returns only this configuration. Match a package against 81298-8112-1 at the FDA source to confirm it is covered.

Namespace context: the Class I index (11 records) and the recall hub (250 records, 118 FDA events); Sunny Pharmtech Inc. (2 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0743-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0743-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-08-12
Ingested
2026-08-22
Record hash
56fa15d58f31f09f

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.